Adult patients with Eisenmenger syndrome report flying safely on commercial airlines

Craig Broberg, Anselm Uebing, Linda Cuomo, Swee Lay Thein, Michael G. Papadopoulos, Michael A. Gatzoulis

    Research output: Contribution to journalArticle

    44 Citations (Scopus)

    Abstract

    Background: Despite fears of compromised oxygen delivery in patients with Eisenmenger syndrome during flight on commercial aircraft, a clinical study has shown no adverse effects, and many patients travel frequently. Methods: The air travel history over the past decade of 53 patients with Eisenmenger syndrome and 48 acyanotic patients was obtained. Patients listed all flights and destinations, and any major adverse event or symptoms, including, specifically, headache, palpitations, oedema or need for supplemental oxygen. For the patients with Eisenmenger syndrome, a full blood count, 6-minute walk test and p50 of the oxygen-haemoglobin dissociation curve were also obtained. Results: 1157 flights were reported evenly between the two groups. Thirteen patients with Eisenmenger syndrome reported no travel in the past 10 years (vs 4/48 acyanotic patients, p = 0.03), six of whom were told not to fly by healthcare providers. Of those who flew, the number and distance of flights was similar in both groups. No major adverse events were reported. One patient with Eisenmenger syndrome possibly had a transient ischaemic attack and a second patient needed supplemental oxygen when exposed to ambient cigarette smoke in flight. Other symptoms such as headache, palpitations and lower extremity oedema at the travel destination were reported with similar frequency in both groups. Patients with Eisenmenger syndrome had a raised p50 of the oxygen-haemoglobin dissociation curve (mean (SD) 29.4 (2.6) mm Hg vs 27 (3) mm Hg in laboratory controls, p

    Original languageEnglish (US)
    Pages (from-to)1599-1603
    Number of pages5
    JournalHeart
    Volume93
    Issue number12
    DOIs
    StatePublished - Dec 2007

    Fingerprint

    Eisenmenger Complex
    Oxygen
    Headache
    Edema
    Hemoglobins
    Air Travel
    Aircraft
    Transient Ischemic Attack
    Smoke
    Tobacco Products
    Health Personnel
    Fear
    Lower Extremity

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Broberg, C., Uebing, A., Cuomo, L., Thein, S. L., Papadopoulos, M. G., & Gatzoulis, M. A. (2007). Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart, 93(12), 1599-1603. https://doi.org/10.1136/hrt.2006.105239

    Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. / Broberg, Craig; Uebing, Anselm; Cuomo, Linda; Thein, Swee Lay; Papadopoulos, Michael G.; Gatzoulis, Michael A.

    In: Heart, Vol. 93, No. 12, 12.2007, p. 1599-1603.

    Research output: Contribution to journalArticle

    Broberg, C, Uebing, A, Cuomo, L, Thein, SL, Papadopoulos, MG & Gatzoulis, MA 2007, 'Adult patients with Eisenmenger syndrome report flying safely on commercial airlines', Heart, vol. 93, no. 12, pp. 1599-1603. https://doi.org/10.1136/hrt.2006.105239
    Broberg C, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart. 2007 Dec;93(12):1599-1603. https://doi.org/10.1136/hrt.2006.105239
    Broberg, Craig ; Uebing, Anselm ; Cuomo, Linda ; Thein, Swee Lay ; Papadopoulos, Michael G. ; Gatzoulis, Michael A. / Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. In: Heart. 2007 ; Vol. 93, No. 12. pp. 1599-1603.
    @article{bdfd4ce1924c43c5a12523d7009b0811,
    title = "Adult patients with Eisenmenger syndrome report flying safely on commercial airlines",
    abstract = "Background: Despite fears of compromised oxygen delivery in patients with Eisenmenger syndrome during flight on commercial aircraft, a clinical study has shown no adverse effects, and many patients travel frequently. Methods: The air travel history over the past decade of 53 patients with Eisenmenger syndrome and 48 acyanotic patients was obtained. Patients listed all flights and destinations, and any major adverse event or symptoms, including, specifically, headache, palpitations, oedema or need for supplemental oxygen. For the patients with Eisenmenger syndrome, a full blood count, 6-minute walk test and p50 of the oxygen-haemoglobin dissociation curve were also obtained. Results: 1157 flights were reported evenly between the two groups. Thirteen patients with Eisenmenger syndrome reported no travel in the past 10 years (vs 4/48 acyanotic patients, p = 0.03), six of whom were told not to fly by healthcare providers. Of those who flew, the number and distance of flights was similar in both groups. No major adverse events were reported. One patient with Eisenmenger syndrome possibly had a transient ischaemic attack and a second patient needed supplemental oxygen when exposed to ambient cigarette smoke in flight. Other symptoms such as headache, palpitations and lower extremity oedema at the travel destination were reported with similar frequency in both groups. Patients with Eisenmenger syndrome had a raised p50 of the oxygen-haemoglobin dissociation curve (mean (SD) 29.4 (2.6) mm Hg vs 27 (3) mm Hg in laboratory controls, p",
    author = "Craig Broberg and Anselm Uebing and Linda Cuomo and Thein, {Swee Lay} and Papadopoulos, {Michael G.} and Gatzoulis, {Michael A.}",
    year = "2007",
    month = "12",
    doi = "10.1136/hrt.2006.105239",
    language = "English (US)",
    volume = "93",
    pages = "1599--1603",
    journal = "Heart",
    issn = "1355-6037",
    publisher = "BMJ Publishing Group",
    number = "12",

    }

    TY - JOUR

    T1 - Adult patients with Eisenmenger syndrome report flying safely on commercial airlines

    AU - Broberg, Craig

    AU - Uebing, Anselm

    AU - Cuomo, Linda

    AU - Thein, Swee Lay

    AU - Papadopoulos, Michael G.

    AU - Gatzoulis, Michael A.

    PY - 2007/12

    Y1 - 2007/12

    N2 - Background: Despite fears of compromised oxygen delivery in patients with Eisenmenger syndrome during flight on commercial aircraft, a clinical study has shown no adverse effects, and many patients travel frequently. Methods: The air travel history over the past decade of 53 patients with Eisenmenger syndrome and 48 acyanotic patients was obtained. Patients listed all flights and destinations, and any major adverse event or symptoms, including, specifically, headache, palpitations, oedema or need for supplemental oxygen. For the patients with Eisenmenger syndrome, a full blood count, 6-minute walk test and p50 of the oxygen-haemoglobin dissociation curve were also obtained. Results: 1157 flights were reported evenly between the two groups. Thirteen patients with Eisenmenger syndrome reported no travel in the past 10 years (vs 4/48 acyanotic patients, p = 0.03), six of whom were told not to fly by healthcare providers. Of those who flew, the number and distance of flights was similar in both groups. No major adverse events were reported. One patient with Eisenmenger syndrome possibly had a transient ischaemic attack and a second patient needed supplemental oxygen when exposed to ambient cigarette smoke in flight. Other symptoms such as headache, palpitations and lower extremity oedema at the travel destination were reported with similar frequency in both groups. Patients with Eisenmenger syndrome had a raised p50 of the oxygen-haemoglobin dissociation curve (mean (SD) 29.4 (2.6) mm Hg vs 27 (3) mm Hg in laboratory controls, p

    AB - Background: Despite fears of compromised oxygen delivery in patients with Eisenmenger syndrome during flight on commercial aircraft, a clinical study has shown no adverse effects, and many patients travel frequently. Methods: The air travel history over the past decade of 53 patients with Eisenmenger syndrome and 48 acyanotic patients was obtained. Patients listed all flights and destinations, and any major adverse event or symptoms, including, specifically, headache, palpitations, oedema or need for supplemental oxygen. For the patients with Eisenmenger syndrome, a full blood count, 6-minute walk test and p50 of the oxygen-haemoglobin dissociation curve were also obtained. Results: 1157 flights were reported evenly between the two groups. Thirteen patients with Eisenmenger syndrome reported no travel in the past 10 years (vs 4/48 acyanotic patients, p = 0.03), six of whom were told not to fly by healthcare providers. Of those who flew, the number and distance of flights was similar in both groups. No major adverse events were reported. One patient with Eisenmenger syndrome possibly had a transient ischaemic attack and a second patient needed supplemental oxygen when exposed to ambient cigarette smoke in flight. Other symptoms such as headache, palpitations and lower extremity oedema at the travel destination were reported with similar frequency in both groups. Patients with Eisenmenger syndrome had a raised p50 of the oxygen-haemoglobin dissociation curve (mean (SD) 29.4 (2.6) mm Hg vs 27 (3) mm Hg in laboratory controls, p

    UR - http://www.scopus.com/inward/record.url?scp=36749073461&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=36749073461&partnerID=8YFLogxK

    U2 - 10.1136/hrt.2006.105239

    DO - 10.1136/hrt.2006.105239

    M3 - Article

    C2 - 17164484

    AN - SCOPUS:36749073461

    VL - 93

    SP - 1599

    EP - 1603

    JO - Heart

    JF - Heart

    SN - 1355-6037

    IS - 12

    ER -